involvement working with the World Health Organization and other
partners aims to eliminate LF by 2020.
-- $31 million of humanitarian product donations for the most impoverished
communities and international relief efforts, including the cyclone in
Bangladesh and floods in Mexico. GSK provides significant quantities of
essential quality medicines through a proven crisis response process.
-- $388 million provided via Patient Assistance Programs (PAP) for low
income patients in the USA. GSK provides $1 million in medicines per
day to patients who cannot afford to pay for their prescriptions. These
include products that are able to be used in an outpatient setting
across all therapeutic areas, such as: respiratory, psychiatric,
neurology, metabolic, CV.
Cash donations of $82 million delivered through partnerships with
hundreds of charitable organizations.
-- Over $41 million was directed to global and local health programs.
With GSK funding the Malaria Consortium is delivering 'Mobilizing for
Malaria', a program to increase awareness and mobilize resources for
this killer disease. In its 15th year, GSK's Positive Action for HIV
and AIDS delivered effective education, prevention and health care
services in 19 countries. GSK's PHASE (Personal Hygiene And Sanitation
Education) program continues to grow now reaching half a million
school children in 12 countries, helping to prevent diarrhoeal diseases
through better hand-washing.
-- Donations of almost $23 million supported education programs,
including science education and literacy. Through Crest Star
Investigators school children will have access to engaging science
activities at their UK after-school clubs. The target is to reach 5,000
schools and 55,000 children by 2
Copyright©2008 PR Newswire.
All rights reserved